FLJ32154: A Potential Drug Target and Biomarker (G149650)

Target Name: FLJ32154

NCBI ID: G149650

FLJ32154

Other Name(s): Uncharacterized protein FLJ32154 | RP11-93B14.6

FLJ32154: A Potential Drug Target and Biomarker

FLJ32154 is a protein that has been identified as a potential drug target and biomarker. Its unique structure and function have captured the interest of researchers and may have significant implications for the development of new treatments for various diseases.

The protein 尾-actinin is a key component of the actin filament that makes up the cytoskeleton of eukaryotic cells. It plays a vital role in the regulation of cell division, cytoskeletal organization, and mechanical forces that arise during cell movement.

FLJ32154 is a unique protein that is expressed in a wide range of tissues and cells, including muscle, nerve, and heart cells. Its structure is very similar to that of 尾-actinin, but it lacks many of the key features that are present in the full-length protein. Instead, it has a distinct N-terminus that is unique to it.

The N-terminus of FLJ32154 is known as the N-terminal hypervariable region (HVR) and is a region that is highly conserved across different species. It is made up of 21 amino acids and is involved in the formation of a distinct protein structure that is different from that of 尾-actinin.

FLJ32154 has been shown to interact with several different protein partners, including the protein casein. This interaction between the protein and casein has been shown to play a role in the regulation of muscle contractions.

Additionally, FLJ32154 has also been shown to interact with the protein LIM, which is a key regulator of cell death. This interaction between the protein and LIM has been linked to the regulation of cell survival and has implications for the development of new treatments for diseases that are characterized by uncontrolled cell growth.

The potential drug target for FLJ32154 is the regulation of cell death, which is a major theme in the development of many diseases. As such, FLJ32154 may be an attractive target for the development of new anti-cancer drugs.

FLJ32154 has also been shown to play a role in the regulation of the cytoskeleton, which is important for many different cellular processes, including cell movement and the development of new tissues. This function of the protein may have implications for the development of new treatments for diseases that are characterized by the disruption of normal cellular processes.

In conclusion, FLJ32154 is a unique protein that has captured the interest of researchers due to its structure and function. Its potential as a drug target and biomarker make it an attractive target for the development of new treatments for a wide range of diseases. Further research is needed to fully understand the role of FLJ32154 in cellular processes and to explore its potential as a drug.

Protein Name: Uncharacterized Protein FLJ32154

The "FLJ32154 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FLJ32154 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets